Related references
Note: Only part of the references are listed.One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose
Scott G. Weiner et al.
ANNALS OF EMERGENCY MEDICINE (2020)
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis
William C. Becker et al.
ANNALS OF INTERNAL MEDICINE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys
David R. Maguire et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys
Vanessa Minervini et al.
PSYCHOPHARMACOLOGY (2020)
National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019
David T. Yeung et al.
JOURNAL OF MEDICAL TOXICOLOGY (2020)
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose
Philip Krieter et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose
Philip Krieter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured to cohort
Jake R. Morgan et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Monoclonal Antibodies for Combating Synthetic Opioid Intoxication
Lauren C. Smith et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Development of vaccines to treat opioid use disorders and reduce incidence of overdose
Marco Pravetoni et al.
NEUROPHARMACOLOGY (2019)
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids
Keith M. Olson et al.
PLOS ONE (2019)
From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery
Joanna Sniecikowska et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of μ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
Lisa R. Gerak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Carfentanil: a weapon of mass destruction
Steven L. Shafer
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2019)
Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys
Lisa R. Gerak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys
David R. Maguire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment
Sandra D. Comer et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Higher doses of naloxone are needed in the synthetic opiod era
Ronald B. Moss et al.
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2019)
Nanoparticles in the clinic: An update
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Covalent Poly(lactic acid) Nanoparticles for the Sustained Delivery of Naloxone
Andrew J. Kassick et al.
ACS APPLIED BIO MATERIALS (2019)
Severe opioid withdrawal precipitated by Vivitrol®
R. S. Wightman et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2018)
The Pharmacokinetics and Pharmacodynamics of Carfentanil After Recreational Exposure: A Case Report
Uvaraj Uddayasankar et al.
PHARMACOTHERAPY (2018)
Naloxone dosage for opioid reversal: current evidence and clinical implications
Rachael Rzasa Lynn et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)
Fatal Fentanyl: One Pill Can Kill
Mark E. Sutter et al.
ACADEMIC EMERGENCY MEDICINE (2017)
Predicting a Drug's Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data
Brian J. Bennion et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2017)
The Role of Science in Addressing the Opioid Crisis
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse
M. D. Raleigh et al.
PLOS ONE (2017)
Polylactic acid (PLA) controlled delivery carriers for biomedical applications
Betty Tyler et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Solution-State Structure and Affinities of Cyclodextrin:Fentanyl Complexes by Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics Simulation
Brian P. Mayer et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2016)
Blockade of dorsolateral pontine 5HT1A receptors destabilizes the respiratory rhythm in C57BL6/J wild-type mice
R. R. Dhingra et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2016)
Biologics to treat substance use disorders: Current status and new directions
Marco Pravetoni
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Opioid Half-lives and Hemlines The Long and Short of Fashion
Evan D. Kharasch
ANESTHESIOLOGY (2015)
5-HT1A Receptor Agonist Befiradol Reduces Fentanyl-induced Respiratory Depression, Analgesia, and Sedation in Rats
Jun Ren et al.
ANESTHESIOLOGY (2015)
The Frequency of Naive and Early-Activated Hapten-Specific B Cell Subsets Dictates the Efficacy of a Therapeutic Vaccine against Prescription Opioid Abuse
Megan Laudenbach et al.
JOURNAL OF IMMUNOLOGY (2015)
Neural Control of Breathing and CO2 Homeostasis
Patrice G. Guyenet et al.
NEURON (2015)
An overview of clinical and commercial impact of drug delivery systems
Aaron C. Anselmo et al.
JOURNAL OF CONTROLLED RELEASE (2014)
An Efficient, Optimized Synthesis of Fentanyl and Related Analogs
Carlos A. Valdez et al.
PLOS ONE (2014)
Mu Opioids and Their Receptors: Evolution of a Concept
Gavril W. Pasternak et al.
PHARMACOLOGICAL REVIEWS (2013)
NMR spectroscopic investigation of inclusion complexes between cyclodextrins and the neurotoxin tetramethylenedisulfotetramine
Brian P. Mayer et al.
MAGNETIC RESONANCE IN CHEMISTRY (2012)
DRUG THERAPY Management of Opioid Analgesic Overdose
Edward W. Boyer
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Repinotan, a Selective 5-HT1A-R-Agonist, Antagonizes Morphine-Induced Ventilatory Depression in Anesthetized Rats
U. Guenther et al.
ANESTHESIA AND ANALGESIA (2010)
The role of medullary serotonin (5-HT) neurons in respiratory control: contributions to eupneic ventilation, CO2 chemoreception, and thermoregulation
Matthew R. Hodges et al.
JOURNAL OF APPLIED PHYSIOLOGY (2010)
Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats
Ms Shagufta Khan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-β-cyclodextrin, not 2,6-di-O-methyl-α-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells
Keiichi Motoyama et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl
Isabel Diaz del Consuelo et al.
JOURNAL OF CONTROLLED RELEASE (2007)
The partial 5-Hydroxytryptamine(1A) receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans
B. G. Oertel et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox
EM Peckham et al.
BRAIN RESEARCH (2005)
Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal
AC Harris et al.
PSYCHOPHARMACOLOGY (2005)
Naloxone in opioid poisoning: walking the tightrope
SFJ Clarke et al.
EMERGENCY MEDICINE JOURNAL (2005)
Unexpected gas casualties in Moscow: A medical toxicology perspective
PM Wax et al.
ANNALS OF EMERGENCY MEDICINE (2003)
Massive OxyContin ingestion refractory to naloxone therapy
AB Schneir et al.
ANNALS OF EMERGENCY MEDICINE (2002)
Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake
SK Sahoo et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery
J Ahonen et al.
BRITISH JOURNAL OF ANAESTHESIA (2000)
Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl
J Liaw et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
